ATE409460T1 - Formulierung zur rektalen verabreichung thrombolytischer wirkstoffe - Google Patents

Formulierung zur rektalen verabreichung thrombolytischer wirkstoffe

Info

Publication number
ATE409460T1
ATE409460T1 AT03767381T AT03767381T ATE409460T1 AT E409460 T1 ATE409460 T1 AT E409460T1 AT 03767381 T AT03767381 T AT 03767381T AT 03767381 T AT03767381 T AT 03767381T AT E409460 T1 ATE409460 T1 AT E409460T1
Authority
AT
Austria
Prior art keywords
thrombolytic
actives
formulation
rectal administration
rectal
Prior art date
Application number
AT03767381T
Other languages
English (en)
Inventor
Miragaya Maria Marrero
Barreto Ana Aguilera
Chavez Lisette Gonzalez
Diaz Eduardo Martinez
Cabrera Beatriz Torrez
Diaz Carelia Cosme
Mayea Milesa Sarmiento
Marrero Luciano Hernandez
Santos Beatriz Tamargo
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE409460T1 publication Critical patent/ATE409460T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03767381T 2002-12-27 2003-12-22 Formulierung zur rektalen verabreichung thrombolytischer wirkstoffe ATE409460T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20020336A CU23203A1 (es) 2002-12-27 2002-12-27 Formulaciones que contienen agentes de accion trombolitica para su administracion por via rectal

Publications (1)

Publication Number Publication Date
ATE409460T1 true ATE409460T1 (de) 2008-10-15

Family

ID=40091670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03767381T ATE409460T1 (de) 2002-12-27 2003-12-22 Formulierung zur rektalen verabreichung thrombolytischer wirkstoffe

Country Status (19)

Country Link
US (1) US10213379B2 (de)
EP (1) EP1576951B1 (de)
JP (1) JP2006512374A (de)
KR (1) KR100804013B1 (de)
CN (1) CN100335128C (de)
AR (1) AR042646A1 (de)
AT (1) ATE409460T1 (de)
AU (1) AU2003291916B2 (de)
BR (1) BRPI0317780B8 (de)
CA (1) CA2527572C (de)
CU (1) CU23203A1 (de)
DE (1) DE60323874D1 (de)
DK (1) DK1576951T3 (de)
ES (1) ES2315537T3 (de)
MX (1) MXPA05007006A (de)
MY (1) MY142241A (de)
PT (1) PT1576951E (de)
WO (1) WO2004058219A1 (de)
ZA (1) ZA200505399B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1660429B (zh) * 2005-01-10 2011-09-07 王振军 基质金属蛋白酶（mmp）抑制剂用于治疗痔的新用途
CN100364610C (zh) * 2005-12-12 2008-01-30 北京大学 提高蚓激酶口服吸收生物利用度的方法
CN102091326B (zh) * 2009-12-15 2013-04-03 上海凯茂生物医药有限公司 治疗因肛门皮下的静脉丛发生扩大或曲张所引发的痔类疾病的经皮给药制剂及制备方法
CN102552916B (zh) * 2010-12-09 2014-04-23 上海凯茂生物医药有限公司 水杨酸钠的新用途
ES2688119T3 (es) * 2015-07-08 2018-10-31 Dr. Falk Pharma Gmbh Formulación farmacéutica para el tratamiento de cambios inflamatorios del recto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
US5098707A (en) * 1989-07-31 1992-03-24 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5720962A (en) * 1995-10-04 1998-02-24 Au Pharmaceuticals, Inc. Analgesic lotion for hemorrhoids and method of making such lotion
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
EP1021195A1 (de) * 1997-10-07 2000-07-26 The Regents Of The University Of California Behandlung okklusiver peripheral-gefässkrankheiten und koronarkrankheiten mit kombinationen aus heparin und adenosin-a2-agonisten, oder mit adenosin
AU7965000A (en) * 1999-09-27 2001-04-30 Jun-Suk Oh Use of analgesics as digestive and medicines for expectorating and transdermal therapeutic system using the same

Also Published As

Publication number Publication date
ES2315537T3 (es) 2009-04-01
CU23203A1 (es) 2007-05-18
AR042646A1 (es) 2005-06-29
BRPI0317780B8 (pt) 2021-05-25
AU2003291916A1 (en) 2004-07-22
PT1576951E (pt) 2009-01-09
CA2527572A1 (en) 2004-07-15
CN1738602A (zh) 2006-02-22
ZA200505399B (en) 2006-04-26
BRPI0317780B1 (pt) 2018-11-21
JP2006512374A (ja) 2006-04-13
DE60323874D1 (de) 2008-11-13
KR20050088219A (ko) 2005-09-02
MXPA05007006A (es) 2005-08-18
EP1576951B1 (de) 2008-10-01
KR100804013B1 (ko) 2008-02-18
EP1576951A1 (de) 2005-09-21
CA2527572C (en) 2010-03-30
AU2003291916B2 (en) 2007-03-08
CN100335128C (zh) 2007-09-05
WO2004058219A1 (es) 2004-07-15
US20070166298A1 (en) 2007-07-19
DK1576951T3 (da) 2009-02-02
US10213379B2 (en) 2019-02-26
MY142241A (en) 2010-11-15
BR0317780A (pt) 2005-11-22

Similar Documents

Publication Publication Date Title
IS7714A (is) Lyfjasamsetningar úr módafíníl
PT1501534E (pt) Formulacoes farmaceuticas
EP1653935A4 (de) Entzündungshemmende formulierungen
NO20034045L (no) Metallproteinase-inhibitorer
DK3536344T3 (da) Superfin formoterolformulering
PT1513514E (pt) Formulações tópicas de hidroximatairesinol
NO20034032D0 (no) Metallproteinase-inhibitorer
NO20044916L (no) Preparater av sulfinylacetamid
ATE414705T1 (de) Entzündungshemmende di- und trifluortriazolopyridin-verbindungen
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
ATE409460T1 (de) Formulierung zur rektalen verabreichung thrombolytischer wirkstoffe
DE60333672D1 (de) Sprühbare ölartige formulierungen
EP1490040A4 (de) Entzündungshemmende formulierungen
NO20013669L (no) Reverse hydroksamatinhibitorer av matriks metalloproteinaser
AR028007A1 (es) Procedimiento para preparar eteres de oxima
ITMI20021455A0 (it) Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico
UA8829S (uk) Комплект санітарно-технічного обладнання
UA8723S (uk) Комплект санітарно-технічного обладнання
FI20020094A7 (fi) Nefriinintapaisten yhdisteiden käyttö
SE0200449D0 (sv) Pharmaceutical formulation
SE0201660D0 (sv) Pharmaceutical formulation
IDP000026456A (id) Senyawa-senyawa siklopropanakarboksilat ester
SE0200008D0 (sv) New pharmaceutically compounds
AT4005U3 (de) Hornhautraspel
FI20025061A0 (fi) Pylväselementti

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1576951

Country of ref document: EP